Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Todd, J.
Right arrow Articles by Hayes, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Todd, J.
Right arrow Articles by Hayes, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology 2003;32:755-762
© International Epidemiological Association 2003


Special Theme: Infectious Diseases

The effects of alternative study designs on the power of community randomized trials: evidence from three studies of human immunodeficiency virus prevention in East Africa

Jim Todd1, Lucy Carpenter2, Xianbin Li3, Jessica Nakiyingi4, Ron Gray3 and Richard Hayes1

1 London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
2 Department of Public Health, Institute of Health Sciences, University of Oxford, Old Road, Oxford OX3 7LF, UK.
3 Johns Hopkins University, Bloomberg School of Public Health, 615 N Wolfe Street, Baltimore, MD 21205, USA.
4 MRC Programme on AIDS in Uganda, PO Box 49, Entebbe, Uganda.

Jim Todd, ITD, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK. E-mail: jim.todd{at}lshtm.ac.uk

Background Randomized intervention trials in which the community is the unit of randomization are increasingly being used to evaluate the impact of public health interventions. In the design of community randomized trials (CRT), the power of the study is likely to be affected by two issues: the matching or stratification of communities, and the number and size of the communities to be randomized.

Methods Data from three East African community intervention trials, designed to evaluate the impact of interventions to reduce human immunodeficiency virus (HIV) incidence, are used to compare the efficiency of different trial designs.

Results Compared with an unmatched design, stratification reduced the between-community variation in the Mwanza trial (from 0.51 to 0.24) and in the Masaka trial (from 0.38 to 0.28). The reduction was smaller in the Rakai trial where the selected communities were more homogeneous (from 0.15 to 0.11). For all trials, individual matching of communities produced estimates of between-community variation similar to those from the stratified designs. The linear association between HIV prevalence and incidence was strong in the Mwanza trial (correlation coefficient R = 0.83) and the Masaka trial (R = 0.83), but weak in the Rakai trial (R = 0.28). Unmatched study designs that use smaller communities tend to increase between-community variation, but reduce the design effect and improve study power.

Conclusions These empirical data suggest that selection of homogeneous communities, or stratification of communities prior to randomization, may improve the power of CRT.


Keywords Intervention studies, community-randomized, between-community variance, sample size, stratification, matching, power, study design, HIV

Accepted 12 February 2003


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin TrialsHome page
S. M Kerry, F. P Cappuccio, L. Emmett, J. Plange-Rhule, and J. B Eastwood
Reducing selection bias in a cluster randomized trial in West African villages
Clinical Trials, April 1, 2005; 2(2): 125 - 129.
[Abstract] [PDF]


Home page
Int J EpidemiolHome page
P. S Brachman
Infectious diseases--past, present, and future
Int. J. Epidemiol., October 1, 2003; 32(5): 684 - 686.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.